Skip to main content
. 2020 Jan 17;157(4):898–906. doi: 10.1016/j.chest.2019.11.043

Table 1.

Characteristics of the Lung Transplant Recipients

Characteristic CF (n = 2,195) COPD (n = 4,858) IPF (n = 6,457)
Recipient age, median (IQR), y 28 (23-37) 61 (56-65) 62 (57-66)
 Age ≥ 18 y 1,989 (91) 4,857 (100) 6,446 (100)
Male sex 1,129 (51) 2,569 (53) 4,676 (72)
Race/ethnicity
 White 2,076 (95) 4,459 (92) 5,285 (82)
 Black 29 (1) 305 (6) 419 (6)
 Hispanic 83 (4) 54 (1) 558 (9)
 Asian 0 12 (0) 144 (2)
 American Indian/Alaska Native 4 (0) 8 (0) 29 (0)
 Native Hawaiian/other Pacific Islander 0 1 (0) 8 (0)
 Multiracial 3 (0) 19 (0) 14 (0)
Transplant year 2010-2015 (reference, 2005-2009) 1,288 (59) 2,722 (56) 4,155 (64)
Private insurance 1,288 (59) 2,155 (44) 3,750 (58)
Height at transplant, median (IQR), cm 165 (159-173) 170 (163-177) 173 (165-178)
Weight at transplant, median (IQR), kg 53 (47-60) 70 (59-81) 82 (71-91)
BMI at transplant, median (IQR), kg/m2 19 (18-21) 24 (21-28) 28 (25-30)
 BMI < 17 kg/m2 352 (16) 76 (2) 31 (0)
Diabetes present 1,034 (47) 420 (9) 1,196 (19)
Oxygen requirement at rest at transplant, median (IQR), L/min 4 (2-6) 3 (2-4) 4 (3-8)
FEV1 % at transplant, median (IQR) 22 (18-27) 20 (16-26) 50 (40-62)
FVC % at transplant, median (IQR) 37 (30-46) 52 (41-64) 45 (36-57)
Lung allocation score at transplant, median (IQR) 41 (37-50) 34 (32-35) 46 (40-61)
On ventilator at transplant 250 (11) 158 (3) 402 (6)
ECMO at transplanta 101 (5) 17 (0) 169 (3)
Bilateral transplant 2,193 (100) 3,082 (63) 3,430 (53)
Repeat transplant 157 (7) 102 (2) 195 (3)

Data are presented as No. (%) unless otherwise indicated. CF = cystic fibrosis; ECMO = extracorporeal membrane oxygenation; IPF = idiopathic pulmonary fibrosis; IQR = interquartile range.

a

ECMO is not consistently captured in the United Network for Organ Sharing Registry for a majority of the study period.